why choose us

300×250 Ad Slot

Drug FDA Status

Showing 10 of 172 result(s) (Page 1 of 18)
Drug Name: Lumvoa

Active Ingredient: veligrotug-vvze

Approval Date: 2026-06-26

Description: To treat thyroid eye disease

Drug Name: Utebzi

Active Ingredient: tebipenem pivoxil

Approval Date: 2026-06-17

Description: To treat complicated urinary tract infections, including pyelonephritis, caused by several susceptible microorganisms in adults who have limited or no alternative oral treatment options

Drug Name: Ambelvist

Active Ingredient: gadoquatrane

Approval Date: 2026-06-12

Description: To detect and visualize lesions with abnormal vascularity, in conjunction with MRI

Drug Name: Zaynich

Active Ingredient: cefepime and zidebactam

Approval Date: 2026-05-29

Description: To treat complicated urinary tract infections, including pyelonephritis, caused by designated susceptible microorganisms

Drug Name: Xocova

Active Ingredient: ensitrelvir

Approval Date: 2026-05-29

Description: To use as post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) following contact with an individual who has COVID-19

Drug Name: Cypsedo

Active Ingredient: cipepofol

Approval Date: 2026-05-29

Description: To induce general anesthesia in adults undergoing surgery

Drug Name: Decnupaz

Active Ingredient: pivekimab sunirine-pvzy

Approval Date: 2026-05-27

Description: To treat adults with blastic plasmacytoid dendritic cell neoplasm

Drug Name: Hepcludex

Active Ingredient: bulevirtide-gmod

Approval Date: 2026-05-22

Description: To treat chronic hepatitis delta virus infection in adults without cirrhosis or with compensated cirrhosis

Drug Name: Baxfendy

Active Ingredient: baxdrostat

Approval Date: 2026-05-15

Description: To treat hypertension in combination with other antihypertensive drugs

Drug Name: Beqalzi

Active Ingredient: sonrotoclax

Approval Date: 2026-05-13

Description: To treat adults with relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase inhibitor

300×250 Ad Slot